Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

23 Sep 2025 07:00

RNS Number : 3357A
System1 Group PLC
23 September 2025
 

 

 

23 September 2025

 

System1 Group PLC (AIM: SYS1)

 ("System1", or "the Company", or "the Group")

 

Q2 Trading Update

 

System1, the marketing decision-making platform www.system1group.com, is today providing a Trading Update ahead of the Company's AGM tomorrow.

 

Trading in the current quarter to 30 September 2025 (Q2) has continued broadly in line with the first quarter, and with one week remaining the Board expects Platform Revenue in the first half of the financial year (H1 FY26) to be similar to the £16.7m in the equivalent period in FY25 (H1 FY25).

 

Whilst the Board had expected the global impact of US trade tariffs to be temporary, the backdrop to trading in Q2 is similar to what we outlined for the first quarter. The Company is continuing to see lower, but ongoing, spend from many of its largest clients, due to the wider macroeconomic uncertainty. This slowdown in spend, together with exchange rate headwinds, which have impacted reported US dollar revenues in particular, has led to the Q2 performance.

 

Overall revenue in H1 FY26 is expected to be approximately 5% lower than in H1 FY25 due to the continued reduction, as planned, in non-platform business. The cash position at end August 2025 remained strong at £10.8m, and the ca £1.4m dividend payments will be made in October.

 

Notwithstanding the challenging market backdrop throughout H1, System1 has continued to win new mandates with a number of the world's largest brands, including for its Innovation product, which is expected to result in revenues from new business wins to be at a similar level to H1 FY25.

 

The Board remains confident in the long-term growth prospects for the Company. We commenced a £2m investment in future growth during FY25 which has largely now been committed and will continue to fuel future growth opportunities. The full year impact of this investment is in FY26. At the same time, as a result of the current trading environment, the Company is keeping a tight rein on non-growth driven expenditure.

 

On 22 October the Company will release its H1 revenue numbers. Alongside this, the Company will host a capital markets webinar in which management will share information on the Innovation products and other growth drivers for the business. Interim results for FY26 are due to be published on 2 December 2025.

 

As a result of H1 trading, the Board expects full year financial performance to be materially below current market expectations2. Revenue for FY26 is expected to be broadly in line with the £37m achieved in FY25 and full year Adjusted PBT1 in a range between £2.0 to £2.5 million, reflecting the Company's increased investment in medium term growth opportunities.

 

Chief Executive Officer James Gregory commented: "While we are seeing a number of new customer wins, these are not yet offsetting the lower spend we are seeing from our existing customer base, and it is disappointing to see the general trading environment in Q2 not improving. But I remain confident that we will return to growth, and we have committed to investment to support this. At the present time our revised outlook represents a cautious view given the ongoing macro-economic uncertainties." 

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

 

1 Statutory Profit Before Taxation excluding share-based payment charges/credits

2 For the purpose of this announcement, the Group believes market expectations for FY26 to be revenue of £42.1m and adjusted profit before taxation of £5.8m.

 

For further information, please contact:

System1 Group PLC

Tel: +44 (0)20 7043 1000

James Gregory, Chief Executive Officer

Chris Willford, Chief Financial Officer

 

Canaccord Genuity Limited (Nominated Adviser & Broker)

 

Tel: +44 (0)20 7523 8000

 

Simon Bridges / Andrew Potts / Harry Rees

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUUURRVNUKUUR
Date   Source Headline
1st May 20264:30 pmRNSHolding(s) in Company
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
21st Apr 20267:00 amRNSQ4 and Full Year Trading Update
9th Apr 20267:00 amRNS-RLaunch of next evolution of Test Your Ad platform
30th Mar 20264:30 pmRNSHolding(s) in Company
30th Mar 20263:30 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Mar 20263:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20264:06 pmRNSBoard Change
2nd Mar 20261:39 pmRNSShareholder update & PDMR Dealing
2nd Mar 20267:00 amRNSDirectorate change
30th Jan 20261:00 pmRNSBoard Committee and Change of Role Update
20th Jan 20267:00 amRNSTrading Update
12th Jan 20264:45 pmRNSAppointment of Joint Corporate Broker
2nd Dec 20257:00 amRNSInterim Results
20th Nov 202511:45 amRNSHolding(s) in Company
24th Oct 20253:28 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSTrading Update
14th Oct 20259:16 amRNSCapital Markets Day
6th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSDirector/PDMR Shareholding - replacement
29th Sep 20255:48 pmRNSDirector/PDMR Shareholding
29th Sep 20251:27 pmRNSHolding(s) in Company
26th Sep 20252:29 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 20253:01 pmRNSResult of AGM
23rd Sep 20257:00 amRNSTrading Update
15th Sep 20251:00 pmRNSDirector/PDMR Shareholding
27th Aug 20254:51 pmRNSNotice of AGM
8th Aug 20254:35 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNSDirector Role Change
9th Jul 20257:00 amRNSFinal Results
9th Jul 20257:00 amRNSTrading Update
4th Jul 202511:45 amRNSHolding(s) in Company
4th Jul 20257:00 amRNSHolding(s) in Company
16th Jun 20251:30 pmRNSHolding(s) in Company
14th May 20257:00 amRNSEstablishment of New Long-Term Incentive Plan
24th Apr 20251:53 pmRNSHolding(s) in Company
23rd Apr 20257:00 amRNSTrading Statement
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Update
8th Jan 202510:15 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSInterim Results
28th Nov 20247:00 amRNSInterim Results Presentation
21st Nov 20243:31 pmRNSHolding(s) in Company
28th Oct 202410:15 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.